Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Delft Imaging Systems
Street 1: Wiltonstraat 41
Street 2:
City: Veenendaal
Province: Gelderland
Post Code: 3905 KW
Country: Netherlands
Phone: 0031318583430
Organization Email:
Web Site:
Other Online Presence:

Focal Point Contact Information

Salutation: Mr
First Name: Harro
Last Name: Nip
Title: Business Unit Director
Phone: +31 318 583 490

Alternate Focal Point Contact Information

Salutation: Mr
First Name: Frank
Last Name: Vijn

General Information

Board Constituency: Private sector
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Organization Description:
Delft believes that every man, woman and child should benefit from advances in healthcare, regardless of where they live. Therefore, we are committed to developing and delivering unique health innovations that respond to the specific needs of vulnerable communities around the world. We focus strongly on providing affordable and innovative diagnostic imaging techniques and solutions that are key to strengthening healthcare systems on a worldwide scale.

Our products and services include computer aided detection software for reading chest X-rays (CAD4TB), design and build of full-service radiology centers, teleradiology solutions for transmitting high quality chest images across mobile networks and reliable and accessible ultrasound screening devices for maternity care. Our reliable, integrated solutions for medical imaging are used globally.

Delft Imaging Systems has collaborative partnerships with Canon, Oldelft and Rogan Delft. In addition, we regularly participate in public private partnerships with NGOs, such as Cordaid and Zambart and knowledge institutes, including Radboud University Medical Center and Newcastle University.

Do you know about the UNHLM declaration:

Specializations / Areas of Work

Provision of drugs, diagnostics and commodities
Research and Development

Other Organization Information

Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 0
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
Together with Canon, Delft Imaging Systems supplies digital x-rays nationwide for the Dutch national health programs for TB checks. This includes our CAD4TB software.

Geographical Reach

Which country is your headquarters located in: Netherlands
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Libyan Arab Jamahiriya
South Africa
United Kingdom of Great Britain and Northern Ireland


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
The overall approach of Delft Imaging Systems is in line with the DOTS approach. The majority of our projects are in Africa (highest rates of TB per capita). In order to ensure local ownership projects are mostly organized in collaboration with the Ministries of Health and local (ngo) partners ensuring the monitoring and evaluation of the investment/ effort. With our OneStop TB clinics, we diagnose suspects and suspects of TB by means of our Computer Aided Detection software. If Tb is flagged, the patient will provide sputum for an additional check (GeneXpert). TB patients can be provided with treatment on their way out.

HIV victims are far more likely to also become affected by TB. Consequently, are diagnostic efforts also aim to team up with local partners/ ngo's that are involved in battling the dual-epidemic. Our project in i.e. Zambia with local partners Zambart and CIDRZ demonstrate our awareness on the issue. Though we have little in house expertise on HIV, we involve local knowledgeable partners that can help integrate this pressing matter in our projects. Creating awareness on and fighting the stigma related to both TB and HIV are fundamental to ensuring that all people can access adequate and timely diagnosis and treatment.

New Diagnostics:
In countries with a high TB burden, sputum smear microscopy is the most common means for diagnosis. Provided the relatively high workload and poor sensitivity, digital chest radiography is a good alternative with large potential in TB case findings. Digital chest radiography uses no film, chemicals or water permitting the reduction of costs and increasing usability of the technique for low-resource areas. Complementary, Delft Imaging Systems CAD4TB, Computer Aided Detection of TB, is a software package that automatically analyzes chest x-rays and is capable of detecting abnormalities that may likely indicate TB. With DIS CAD4TB, skilled radiologists are no longer required to interpret chest-x-rays screening of remote populations in under-serviced areas. With our portable solution, OneStopTB Clinics, at least a 100 people are scanned daily and diagnosed that very same day. CAD4TB is highly sensitive, accessible and cost-effective. Our CAD4TB software has been extensively tested and researched leading to four new releases of which the last version has been CE certified this April. Our last CAD4TB V 4.10 is CE certified and is currently in use in several countries around the world.

We closely collaborate with local partners in the field, for research on our ongoing TB projects. Though we currently have a marketable product, improvements will always be necessary in order to continue to ensure effectiveness. We remain critical of our product and continue to learn from feedback and research from the field. We have come far but we will nevertheless continue to search for ways as to optimize (evaluation of accuracy) our approach in close collaboration with all of our partners.


Declaration of interests:

Application date: April 24, 2015
Last updated: April 29, 2018